Description
Aging is the predominant risk factor for developing Alzheimer's disease (AD) and other dementias. Recently, DNA methylation has been used to estimate the brain age and the brain age acceleration (defined as the difference between its biolog…
Amendment chain · 2 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $114,400 at start, $114,400 after amendment #1 (+$0).
- #02022-09-01$114,400
- #12025-09-03$114,400
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2022-09-01(start date) | $114,400 | — | Aging is the predominant risk factor for developing Alzheimer's disease (AD) and other dementias. Recently, DN… |
| #1 amendment | 2025-09-03 | $114,400 | +$0 | Aging is the predominant risk factor for developing Alzheimer's disease (AD) and other dementias. Recently, DN… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 130104466)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 207-2024-2025-Q4-00536 | Social Sciences and Humanities Research Council of Canada | Conseil de recherches en sciences humaines du Canada · New Frontiers in Research Fund | $249,750 | FY2025 |
| 1480-2021-2022-Qrt3-0000044 | Public Health Agency of Canada | Agence de la santé publique du Canada · Health Promotion and Chronic Disease Prevention | $9,578,486 | FY2022 |
| 1480-2022-2023-Qrt3-0000057 | Public Health Agency of Canada | Agence de la santé publique du Canada · Health Promotion and Chronic Disease Prevention | $500,000 | FY2022 |
| 172-2020-2021-Q4-965532 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives | $107,996 | FY2021 |
| 1480-2019-2020-Qrt4-0000529 | Public Health Agency of Canada | Agence de la santé publique du Canada · Health Promotion and Chronic Disease Prevention | $940,000 | FY2020 |
| 135-2018-2019-Q4-000020 | Public Health Agency of Canada | Agence de la santé publique du Canada · Health Promotion and Chronic Disease Prevention | $236,993 | FY2019 |
Other recipients funded under "Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2026-2027-Q1-1044103 | York University | FY2027 | $462,000 | FY2027 |
| 172-2026-2027-Q1-1043787 | Simon Fraser University | FY2027 | $279,766 | FY2027 |
| 172-2026-2027-Q1-1044229 | Noram Electrolysis Systems Inc. | FY2027 | $300,053 | FY2027 |
| 172-2026-2027-Q1-1043305 | University of Ottawa | FY2027 | $418,000 | FY2027 |
| 172-2026-2027-Q1-1043602 | University of Windsor | FY2027 | $99,000 | FY2027 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2021-2022-Q1-991333 · retrieved 2026-11-15.